Overcoming global antimicrobial resistance. AMR control. WAAAR 2015, Carlet.pdf), 2015. ,
Re-establishing a place for phage therapy in western medicine, Future Microbiology, vol.10, issue.5, pp.685-693, 2015. ,
DOI : 10.2217/fmb.15.28
Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials, PLoS ONE, vol.158, issue.3, p.4944, 2009. ,
DOI : 10.1371/journal.pone.0004944.s002
Clinical Aspects of Phage Therapy, Adv Virus Res, vol.83, pp.73-121, 2012. ,
DOI : 10.1016/B978-0-12-394438-2.00003-7
Quality and Safety Requirements for Sustainable Phage Therapy Products, Pharmaceutical Research, vol.313, issue.7, pp.2173-2182, 2015. ,
DOI : 10.1007/s11095-014-1617-7
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452253
The Phage Therapy Paradigm: Pr?t-?-Porter or Sur-mesure?, Pharmaceutical Research, vol.2, issue.4, pp.934-941, 2011. ,
DOI : 10.1038/nrmicro822
Time for Tailored Antimicrobials, Critical Care Medicine, vol.43, issue.6, pp.1346-1353, 2015. ,
DOI : 10.1097/CCM.0000000000001038